Show simple item record

Asciminib in chronic myeloid leukemia: many questions still remain to be answered

dc.contributor.authorEŞKAZAN, Ahmet Emre
dc.date.accessioned2021-12-10T10:20:57Z
dc.date.available2021-12-10T10:20:57Z
dc.date.issued2021
dc.identifier.citationEŞKAZAN A. E. , "Asciminib in chronic myeloid leukemia: many questions still remain to be answered", BLOOD CANCER JOURNAL, cilt.11, sa.4, 2021
dc.identifier.issn2044-5385
dc.identifier.othervv_1032021
dc.identifier.otherav_39ffb192-d737-43fe-8036-49bbfea92df6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169714
dc.identifier.urihttps://doi.org/10.1038/s41408-021-00475-7
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHematology
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAsciminib in chronic myeloid leukemia: many questions still remain to be answered
dc.typeMakale
dc.relation.journalBLOOD CANCER JOURNAL
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume11
dc.identifier.issue4
dc.contributor.firstauthorID2634335


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record